Atherosclerotic Cardiovascular Disease Risk Assessment

Share this content:
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK ASSESSMENT
Implementation of Risk Assessment
Work Group Recommendations
                 
  Does the patient have existing
clinical ASCVD?
Yes See AHA/ACC Secondary
Prevention Guideline
 
       
     
No
 
     
   
  Is the patient <20 years or
>79 years of age?
 
Yes
See Pediatric Guidelines and ACC/AHA
Adult Primary Prevention Guidelines
  • Blood Cholesterol
  • Obesity
 
 
 
     
No
 
 
     
  Assess traditional risk factors every 4–6 years
in patients 20–79 years of age; estimate
10-year risk in those 40–79 years of age
using Pooled Cohort Equations
Elevated
10-year risk
(≥7.5%)
 
 
 
Communicate risk data
and refer to AHA/ACC
Prevention Guidelines
  • Blood Cholesterol
  • Obesity
 
 
 
     
Low
10-year risk
(<7.5%)
 
 
     
  Assess 30 year or lifetime risk in those
20–59 years of age; Communicate risk data
regardless of age and refer to AHA/ACC Lifestyle
Guideline
 
 
             

American College of Cardiology (ACC) and the American Heart Association (AHA) have released a new clinical practice guideline to assist primary care clinicians in identifying adults who may be at high risk for developing atherosclerotic cardiovascular disease (ASCVD) and who may benefit from lifestyle changes or drug therapy for prevention. The figure above is a suggested approach for incorporating ASCVD risk assessment recommendations made by the Work Group into clinical practice.

REFERENCES

Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013.
Available at: http://circ.ahajournals.org/content/early/
2013/11/11/01.cir.0000437741.48606.98.full.pdf+html
.

(Rev 5/2015)

You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus